Evidence map›Paper›PMID 36443602›Full record

ArticleBritish journal of cancer2023

Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis.

Rachel H Horton, Malcolm G Dunlop, Richard S Houlston, Anneke Lucassen, Margaret McCartney, Alan McNeill, Amit Sud

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Rachel H HortonClinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK.
Malcolm G DunlopColon Cancer Genetics Group, Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Richard S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.ORCID 0000-0002-5268-0242
Anneke LucassenClinical Ethics and Law, Faculty of Medicine, University of Southampton, Southampton, UK.
Margaret McCartneyPopulation and Behavioural Science Division, School of Medicine, University of St Andrews, St Andrews, UK.
Alan McNeillEdinburgh Urological Cancer Group, University of Edinburgh, Western General Hospital, Edinburgh, UK.
Amit SudDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. amit.sud@icr.ac.uk.ORCID 0000-0002-6133-0164

Funding

Cancer Research UK 12076Cancer Research UK 18927Medical Research Council MC_PC_U127527198Medical Research Council MC_U127527198Medical Research Council MC_UU_00007/1Wellcome Trust 218092
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

OverdiagnosisProstatic NeoplasmsEarly Detection of CancerHumansMaleMass ScreeningMedical OveruseProstate-Specific AntigenRisk FactorsProstate-Specific Antigen

Identifiers

PMID36443602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.